GlassScriptPhysician profile
Richard Mathias
NPI 1124305875
$2,510.11
in general payments reported to CMS, 2019-2025
8 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $305 · 2021: $1,257 · 2022: $675 · 2023: $50.00 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $100 · Honoraria: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $100.00 |
| Honoraria | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,575.00 | 2019-2022 | |
| Zimvie INC. | $450.00 | 2022 | |
| Straumann USA LLC | $300.00 | 2021-2025 | |
| Galderma Laboratories, L.P. | $72.79 | 2019 | |
| Mckesson Medical-Surgical, INC. | $50.00 | 2023 | |
| Hu-Friedy Mfg. Co., LLC | $30.00 | 2020 | |
| Kulzer, LLC | $20.00 | 2021 | |
| 3m Company | $12.32 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mathias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.